Effects of Nebivolol on Left Ventricular and Left Atrial Morphodynamics in Adults With Hypertension and Isolated Diastolic Dysfunction

Trial Profile

Effects of Nebivolol on Left Ventricular and Left Atrial Morphodynamics in Adults With Hypertension and Isolated Diastolic Dysfunction

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Nov 2017

At a glance

  • Drugs Nebivolol (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2016 Status changed from recruiting to completed.
    • 23 Sep 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 according to the ClinicalTrials.gov record.
    • 23 Sep 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 according to the ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top